Rituximab for the treatment of Churg-Strauss syndrome with renal involvement

The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis)

(2010) Alfonse T. Masi et al.   ARTHRITIS AND RHEUMATISM

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Severe bronchospasm associated with rituximab for refractory Churg-Strauss syndrome

(2009) M-A Bouldouyre et al.   ANNALS OF THE RHEUMATIC DISEASES

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis

(2009) Rachel B. Jones et al.   ARTHRITIS AND RHEUMATISM

Churg-Strauss syndrome successfully treated with rituximab

(2009) Kristin Kveim Dønvik et al.   RHEUMATOLOGY INTERNATIONAL

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis

(2008) P A Merkel et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production

(2008) R. J. Pepper et al.   RHEUMATOLOGY